We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to ...

Rating upgraded from 74 to 83 Friday. This unique rating tracks market leadership by showing how a stock's price action over ...

AI stock Astera Labs is looking to rebound from a key support level the stock market today following a 47% advance in recent ...

The scientific team at the laboratory is headed by a group of women with a track record in genomic science, molecular ...